Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLD2 | O14939 | 13/20 | 0.51 |
| ▸ | PLD1 | Q13393 | 12/20 | 0.51 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.43 |
| ▸ | CCR1 | P32246 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4805216 | 0.88 | PLD2 (0.59) | PLD2PLD1OPRL1OPRM1CHRM1 | |
| SCHEMBL4808944 | 0.87 | OPRL1 (0.57) | PLD2PLD1OPRL1OPRM1CHRM1 | |
| Hydrochloric Acid SCHEMBL4805718 | 0.86 | OPRL1 (0.56) | PLD2PLD1OPRL1OPRM1CHRM1 | |
| Hydrochloric Acid SCHEMBL4805706 | 0.86 | OPRL1 (0.56) | PLD2PLD1OPRL1OPRM1CHRM1 | |
| SCHEMBL4807512 | 0.86 | PLD2 (0.66) | PLD2PLD1OPRL1OPRM1DRD2 | |
| SCHEMBL4804373 | 0.86 | PLD2 (0.60) | PLD2PLD1OPRL1CHRM1DRD2 | |
| SCHEMBL4806305 | 0.84 | PLD2 (0.59) | PLD2PLD1OPRL1 | |
| SCHEMBL6791524 | 0.82 | SCN1A (0.45) | OPRL1CCR1KCNH2 | |
| SCHEMBL4805869 | 0.81 | PLD2 (0.57) | PLD2PLD1OPRL1OPRM1CHRM1 | |
| SCHEMBL4805878 | 0.81 | PLD2 (0.57) | PLD2PLD1OPRL1OPRM1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7388020-B2 | Benzimidazol derivatives modulate chemokine receptors | ASTRAZENECA AB (SE) | 2008-06-17 | — | — | US | claimed |
| EP-1373248-A1 | BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS | AstraZeneca AB (SE) | 2004-01-02 | — | — | EP | claimed |
| WO-2002074763-A9 | BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS | ASTRAZENECA AB (SE) | 2002-10-24 | — | — | WO | claimed |
| WO-2002074763-A1 | BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | claimed |
| US-7388020-B2 | Benzimidazol derivatives modulate chemokine receptors | ASTRAZENECA AB (SE) | 2008-06-17 | — | — | US | disclosed |
| US-20040116435-A1 | Benzimidazol derivatives modulate chemokine receptors | ASTRAZENECA AB (SE) | 2004-06-17 | — | — | US | disclosed |
| EP-1373248-A1 | BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS | AstraZeneca AB (SE) | 2004-01-02 | — | — | EP | disclosed |
| WO-2002074763-A9 | BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS | ASTRAZENECA AB (SE) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002074763-A1 | BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | disclosed |